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ABSTRACT

In this work, we develop a simple mathematical model to observe the spread of
COVID-19 and vaccine administration in Mississippi. Based on the well-known
Kermack-McKendrick Susceptible-Infected-Removed epidemiological model, the
ASIRD −V model has eight ordinary differential equations that split infected populations
and recovered populations into vaccinated and unvaccinated populations. After determining
that the system is reliable for real-world applications, we investigate and determine the
stability and equilibrium points of this system. The system is found to be disease-free when
R0 < 1 and endemic when R0 > 1. We use MATLAB to numerically solve the system and
optimize the model’s parameters over four short periods, two with the presence of vaccines
and two without the presence of vaccines, using death data and vaccine data given by the
Centers for Disease Control. By calculating the reproduction numbers of the time periods,
we analyze the effects of certain policy changes as well as the reliability of this model in
predicting the spread of the disease. While the health policies at the start of the pandemic
are reliable short-term solutions to slow the spread, the presence of fully vaccinated
individuals slows the spread in the long term.

Keywords: COVID-19, ASIRD-V model, Stability, Parameter optimization, Vaccinations,
Reproduction number, Numerical simulation
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CHAPTER I: INTRODUCTION
In December of 2019, Severe Acute Respiratory Coronavirus 2
(SARS-CoV-2), which is known to cause COVID-19, was discovered in many patients
battling pneumonia in Wuhan, China. By spreading through airborne particles and infected
surfaces, COVID-19 traveled throughout the world, and the World Health Organization
(WHO) declared this epidemic an international health emergency by January 30, 2020. This
disease spreads through the air and surfaces much like the influenza viruses, although the
coronavirus is much more infectious. In addition, influenza viruses have preventative
vaccines, so COVID-19 spread comparatively faster without that control measure. By
March 6, 2020, the first case of COVID-19 appeared in Mississippi, and by March 11 the
WHO declared COVID-19 a pandemic, giving rise to the "new normal" as we live with the
virus today.
Symptoms of COVID-19 appear approximately between 2 to 14 days after exposure
and can range from asymptomatic to severe. Symptoms commonly include fever, chills,
cough, shortness of breath or difficulty breathing, loss of taste and smell, and nausea. While
most people only acquire mild symptoms, others such as the elderly and those with certain
underlying health problems are at greater risk of contracting severe symptoms. While
treatments for mild symptoms include fever reducers and rest, more severe symptoms could
land an individual in the hospital. The case fatality rate in the United States began at
approximately 2%, and the case fatality rate fluctuated as the coronavirus spread during the
pandemic [26]. COVID-19 is known to cause an inflammation of the lungs known as Acute
Respiratory Distress Syndrome (ARDS), and this requires a ventilator for assistance in
fighting the disease. Many other complications have been known to arise from COVID-19,
and the severity of these complications can be deadly. Following health guidelines
determined by the World Health Organization and the Centers for Disease Control (CDC) is
crucial to prevent more deaths from occurring in the United States of America.
Without a vaccine for COVID-19, preventative measures had to consist solely of
quarantine, social distancing, increased hygiene, masks, and isolation. With guidance from
1

the CDC and the Mississippi Department of Human Service (MDHS), Mississippi Governor
Tate Reeves enacted several Executive Orders as preventative measures against this disease
throughout the pandemic [22]. These included state- and county-wide mask mandates, the
closing of schools and nonessential businesses for a short period, Safer-At-Home orders
encouraging the population to maintain isolation, and social distancing without large
gatherings. Meanwhile, pharmaceutical companies Pfizer and Moderna were rapidly
developing the mRNA vaccines, finally releasing the first doses in Mississippi by December
of 2020 [12]. The COVID-19 pandemic became a crisis as Mississippi officials, as well as
United States officials, scrambled to find the best solutions to curbing the rate of infections.
The field of epidemiology uses mathematical modeling to help these policymakers in their
decisions.
For epidemiologists, COVID-19 opened new research to study the effects and spread of
this new virus and predict its spread to inform health officials and policymakers. The
research includes developing new mathematical models to understand how transmission
occurs in a given population. The asymptomatic cases discovered in the pandemic spurred
many model variations, some more complicated than others, and as more information about
the disease was released, the more accurate these mathematical models could become. In
addition, the mutation of COVID-19 into several variants has provided an opportunity to
compare transmission rates and accuracy in different models. In this study, we have
explored many of these models, and the complexity of many of these models provided
accurate simulations and predictions. However, in this study we developed a simple model
that accounts for asymptomatic cases as well as the eventual introduction of vaccine
administrations in Mississippi.
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CHAPTER II: LITERATURE REVIEW
Many of these epidemiological models are based on basic variations of the Kermack
and McKendrick Susceptible-Infected-Removed (SIR) model [1]. However, very few
models included compartments for both asymptomatic cases and a vaccinated control
measure. Many of these models varied widely in complexity and included several
compartments to accurately simulate and predict the spread of COVID-19. Depending on
what the researchers wanted to observe and understand, different parameters, compartments,
and control mechanisms were added to these systems. In addition, some of these models
were made to observe long, continuous time periods while others were made to observe
short time periods in the pandemic.
In epidemiological models, the basic reproduction number, R0 , is the expected number
of secondary cases caused by one infected individual. This number is a threshold parameter
that tells us whether a disease will sustain in a population or eventually die out. If R0 < 1,
then eventually there will not be enough infected individuals to spread the disease, and the
disease will stop spreading. If R0 > 1, then more people will become infected as time
passes, and the disease will spread. The reproduction number of a model arises from
theoretical analysis, and [6] presented the Next-Generation matrix method to derive the
reproduction number based on the disease-free equilibrium of the system. The reproduction
number of a system is crucial to analyzing the spread of diseases since it provides an
indication of the infectiousness of a disease and quantifies it. Since the infectiousness of a
disease depends on many factors, the reproduction number is not the same for all models
and countries. The reproduction number can change throughout time, caused by outside
factors such as health control measures and vaccine effectiveness.
This research is an extension of the 2021 Undergraduate Summer Cross Scholar
Research Program at the University of Southern Mississippi. In the 2021 summer research
program, a simple model was developed to analyze the beginning of the pandemic in
Mississippi, the ASIRD model [16]. The literature reviewed for the ASIRD model was
written at the beginning of the pandemic before and immediately after vaccines were
3

developed.
In 2021, Abdy et al. used a fuzzy parameter in their SIR model to reflect real-world
problems such as uncertainty in testing [2]. In addition, by using the basic SIR model, they
added parameters for vaccine effectiveness and treatment effectiveness in the removed
compartment. The membership functions of the fuzzy parameters incorporated in the SIR
model allowed for dependence on the capacity to carry the disease by an individual. Abdy
et al. simulated the effects of vaccines, treatments, and infections by using data from
Indonesia effectively [2]. We take away from this model the idea that measuring uncertainty
in our model will be useful to gain an understanding of the effects of infections.
Krivorot’ko et al. studied the reliability of the SEIR − D and SEIR − HCD models and
compared their simulation results to find the best fit and accurate simulation of the
pandemic in Moscow and the Novosibirsk region [3]. In their research, the SEIR − D model
created the most accurate simulations for the Novosibirsk region and the best historical
approximation of cases and deaths in Moscow. In addition, the SEIR − D model had the
smallest error in forecasting the longest period for Moscow [3]. Krivorot’ko et al. displayed
the importance of available information to the reliability of a model. Without sufficient data
available for the model to measure, a model will not be as effective in simulating or
forecasting the spread of the disease. In our study, we wanted to utilize the data made
available to us to create a reliable model.
Neves and Guerrero introduced a simple variation of the SIR model by adding an
asymptomatic compartment and developed the A − SIR model to study the COVID-19
pandemic in Italy and Brazil [23]. By adding a compartment for asymptomatic individuals,
the model accounted for the unpredictability of those who are positive with COVID-19 but
not tested either due to the lack of testing or the lack of recognizable symptoms. From the
literature above, the ASIRD model developed in the Cross Scholar Summer Research
program is a variation of the models studied in the references [24] [23], where we wanted to
observe the effects of the asymptomatic cases with the data on deceased individuals made
available by MDHS and the CDC. Through the Cross Scholar Summer Research program,
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we simulated the ASIRD model over the beginning of the pandemic and discovered the
model most effectively simulated the pandemic for short periods of time. In the modification
of the ASIRD model to include vaccinations, the following literature was reviewed.
Ramos et al. began with a simple but complex enough θ − SIR type model in
application to the COVID-19 pandemic in Italy [5]. The θ − SEIHQRD model developed
by Ramos et al. added all necessary complexities to a traditional SIR model that are
important to helping policymakers, with data and research to support each parameter.
Bachar et al. modeled the spread of COVID-19 and control mechanisms in Saudia Arabia
using numerical simulations of their SL SM EIU ID Ru RD Ex system for a short time [11]. The
system of Bachar et al. split infected and recovered compartments into undiagnosed and
diagnosed, an interesting take on the uncertainty of testing. Meanwhile, Hongfan et al. used
a SIQR model with a time delay for COVID-19 to consider the impact of treatment time and
its effect on the pandemic using numerical simulations [25]. In one research article, the
basic reproduction number of COVID-19 is estimated in Ghana using an SEIAHR model
and the next-generation matrix method, which we found helpful in finding the basic
reproduction number for our system [15]. One study also included the complexity of adding
the dynamics of another disease alongside COVID-19; although far too complex for an
application to the population of Mississippi, it offered an interesting insight into the
dynamics of different diseases within a pandemic [14].
In this study, we considered asymptomatic cases as an unpredictable but important
factor to include in simulations and predictions. Since asymptomatic individuals can infect
others with the disease without showing symptoms, including these individuals is important
to understand how the disease spreads. Olivares et al. developed an SEIs Ia QR model to
quantify uncertainty under a mass vaccination strategy, where asymptomatic individuals
were placed in the compartment Ia [9]. Aziz-Alaoui et al. introduced a simple yet effective
SIARD model focused on non-total immunity while observing the death rate of
asymptomatic individuals in a stochastic approach [24]. While the SIARD model is similar
to the one we develop in this study, we did not consider the reinfection rate because of the
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short time periods we observed.
Since the vaccine for COVID-19 was developed almost a year after the spread was
declared a pandemic, many models did not include vaccine mechanisms or vaccinated
compartments. However, once the administration of the vaccines began, researchers were
able to include vaccine compartments and mechanisms in their models to observe the effect
of different administration policies around the world. In another study, Ramos et al. refined
their previous research and developed a θ − i j − SV EIHQRD model for the impact of
variants and vaccines on the pandemic in Italy [10]. By including a vaccination
compartment, they were able to study the effectiveness of the vaccines against different
COVID-19 variants. Although they did not include a separate compartment for a vaccinated
population, De la Sen et al. used parameters to estimate vaccine and antiviral controls in
their SEIs Ih AR model [7]. In addition, Zhang et al. developed a discretized SIRV S model to
study the permanence of a disease with vaccinations present [8]. While the SIRV S model
was not in any particular application to the COVID-19 pandemic, it provided a useful basis
for adding vaccination compartments into a system.
While not as simple as the A − SIR model, the model we developed includes a death
compartment for more accurate optimization as well as a vaccine compartment to account
for the vaccine control measures beginning farther into the pandemic. Based on the available
data for Mississippi, we chose compartments for the vaccinated, asymptomatic, susceptible,
infected, recovered, and deceased populations. Some of these compartments were split to
observe the effect of possible breakthrough cases as vaccine efficacy decreased [17]. The
ASIRD −V model was developed since we did not want to introduce compartments without
having sufficient data to support an accurate simulation of the spread of the disease. The
simplicity of the model takes the deceased data, vaccine data, and confirmed cases data of
Mississippi as support for simulations made in this study. The vaccine efficacy for
COVID-19 in certain time periods is also known and provided by the CDC [12] [13].
The next section of this study is the development of the ASIRD −V model for
COVID-19 in Mississippi. In Chapter III, we developed the methodology for creating the
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ASIRD −V model, conducted an equilibrium analysis, and proved the linear stability using
the basic reproduction number of the system. In Chapter IV, we simulated the model
numerically and showed results for short time spans at the beginning of the pandemic, in the
time span during the first doses of administered vaccines, and in the time span for fully
vaccinated, susceptible individuals. By comparing the reproduction number of each
simulation, we observed the effect of vaccinations and other health policies on the pandemic
in Mississippi. Finally, we deduced conclusions in Chapter V from the results in Chapter IV.

7

CHAPTER III: METHODOLOGY
The Asymptomatic-Susceptible-Infected-Recovered-Deceased (ASIRD) model was
altered to accommodate those who have been vaccinated against COVID-19 [16]. While
this vaccination occurred, the disease began to spread widely, providing the chance for
vaccine effectiveness to drop and cause breakthrough cases [19]. Since these breakthrough
cases accounted for a significant part of the population, the vaccinated compartment was
treated as a susceptible compartment, where those who were in the susceptible population
may receive the vaccine with an immunity rate lower than 90% [20] [19]. In addition, some
studies showed the predominance of the Delta variant decreased the effectiveness of two
doses of the Pfizer or Moderna vaccines (mRNA) to only 66% among healthcare workers
and as low as 53% among nursing home residents [17] [18]. Any breakthrough cases
traveled to the vaccinated, asymptomatic compartment, where the vaccinated but infected
could infect others. Those who are positive for COVID-19 but vaccinated experienced
milder symptoms than those without the vaccine. To study the effect of this small
population, the asymptomatic compartment was split to observe those with and without the
vaccine and how these two populations recovered differently [19]. The recovered
compartments contain those who have recovered from illness, so those who were immune
because of the vaccine stayed in the vaccinated compartment since there was no logical
reason to move them to the recovered compartment if they had never been infected.
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ASIRD-V Model

dS
dt
dI
dt
dAu
dt
dAv
dt
dRu
dt
dRv
dt
dD
dt
dV
dt

= −S(αI I + αA Au + αA Av ) − νS
= ξ S(αI I + αA Au + αA Av ) − (ρs + µ)I
= (1 − ξ )S(αI I + αA Au + αA Av ) − ρau Au
= (1 − τ)V (αI I + αA Au + αA Av ) − ρav Av
(1)
= ρs I + ρau Au
= ρav Av
= µI
= νS − (1 − τ)V (αI I + αA Au + αA Av )

Figure 1: Schematic for ASIRD-V Model
The system of ordinary differential equations has nine parameters that move individuals
from one compartment to the next. Each compartment is a population represented by an
ordinary differential equation. We have the susceptible population S, which we assumed to
be the entire population of Mississippi. Susceptible individuals are vaccinated at a rate of ν
or become infected at a rate of αI or αA . Since we are observing the pandemic for short
periods of time, we assumed no reinfections occur from recovered individuals during each
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time period. We also assumed that breakthrough cases could occur in the vaccinated
population V since the vaccine efficacy τ cannot represent total immunity to the disease.
There is a probability of (1 − τ) that a breakthrough case occurs, and vaccinated,
susceptible individuals become infected at a rate of αA . Meanwhile, we have three
infectious populations: the symptomatic infected I, the unvaccinated asymptomatic Au , and
the vaccinated asymptomatic Av . There is a probability ξ that a susceptible individual
develops symptoms, and a probability (1 − ξ ) that a susceptible individual becomes
asymptomatic. We assumed that both unvaccinated and vaccinated asymptomatic
individuals have little to no symptoms with no testing and no hospitalization or death;
symptomatic individuals have symptoms severe enough to be tested and quarantined, as
well as possible hospitalization and death. However, we assumed that vaccinated and
infected individuals recover differently at a rate of ρav than both unvaccinated symptomatic
and asymptomatic individuals with a recovery rate of ρs or ρau , respectively. There are two
recovered populations: the unvaccinated recovered Ru and the vaccinated recovered Rv . The
symptomatically infected individuals transfer to the deceased population D at a death rate of
µ. Figure 1 shows the flow of individuals as parts of the susceptible population become
vaccinated, infected, or both, and eventually recover or die. The infection rates of
symptomatic and asymptomatic individuals are αI and αA , respectively, and ξ is the
probability a case becomes symptomatic. The recovery rates for symptomatic and
asymptomatic individuals without vaccines are ρs and ρau while the recovery rate for
breakthrough cases is ρav . The death rate is described by the parameter µ, where only those
with severe symptoms in the infected population could die. The daily vaccination rate is
described by the parameter ν while the immunity rate of the vaccines is described by τ. To
show that this system can simulate the pandemic with reasonable results, we first proved
that the solutions of the system are nonnegative and bounded.

Equilibrium analysis
Lemma III.2.1. System (1) has nonnegative solutions and is bounded.
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Proof:
Let the initial conditions at t0 be S(t0 ), I(t0 ), Au (t0 ), Av (t0 ), Ru (t0 ), Rv (t0 ), D(t0 ),V (t0 ) ≥ 0.
Note that

dS
dt

dAv
dRv
dAu
dRu
dD
dV
+ dI
dt + dt + dt + dt + dt + dt + dt = 0. This implies that the solution

S + I + Au + Av + Ru + Rv + D +V = N, the constant population number which is scaled to
1. From system (1), we assume for any t ≥ 0:
dS
dt
dI
dt
dAu
dt
dAv
dt
dRu
dt
dRv
dt
dD
dt
dV
dt

≥ −(αI I + αA Au + αA Av + ν)S
≥ (ξ SαI − (ρs + µ))I
≥ ((1 − ξ )SαA − ρau )Au
≥ ((1 − τ)V αA − ρav )Av
(2)
≥0
≥0
≥0
≥ −(1 − τ)(αI I + αA Au + αA Av )V

Then the solutions at the initial conditions for each equation can be found with the
separation of variables and integration:
Z

dS ≥

Z

−(αI I + αA Au + αA Av + ν)Sdt ⇒ S(t) ≥ S(t0 )e−(αI I+αA Au +αA Av +ν)t0 ≥ 0
Z

Z
Z

dI ≥

dAu ≥
dAv ≥

Z

(ξ SαI − (ρs + µ))Idt ⇒ I(t) ≥ I(t0 )e(ξ SαI −(ρs +µ))t0 ≥ 0

Z

((1 − ξ )SαA − ρau )Au dt ⇒ Au (t) ≥ Au (t0 )e((1−ξ )SαA −ρau )t0 ≥ 0

Z

((1 − τ)V αA − ρav )Av dt ⇒ Av (t) ≥ Av (t0 )e((1−τ)V αA −ρav )t0 ≥ 0
Z
Z
Z
Z

dRu ≥
dRv ≥
dD ≥

dV ≥

Z

Z

0dt ⇒ Ru (t) ≥ Ru (t0 )e0t0 ≥ 0

Z

0dt ⇒ Rv (t) ≥ Rv (t0 )e0t0 ≥ 0

Z

0dt ⇒ D(t) ≥ D(t0 )e0t0 ≥ 0

−(1 − τ)(αI I + αA Au + αA Av )V dt
⇒ V (t) ≥V (t0 )e−(1−τ)(αI I+αA Au +αA Av )t0 ≥ 0
11

(3)

Therefore, the system has nonnegative solutions for t ≥ t0 . As a consequence of being
nonnegative and S + I + Au + Av + Ru + Rv + D +V = N = 1,
S(t) ≤ N, I(t) ≤ N, Au (t) ≤ N, Av (t) ≤ N, Ru (t) ≤ N, Rv (t) ≤ N, D(t) ≤ N,V (t) ≤ N and
S(t) + I(t) + Au (t) + Av (t) + Ru (t) + Rv (t) + D(t) +V (t) = N for all t ≥ t0 , and thus the
system (1) is bounded.
We observed the disease-free equilibrium when I = I 0 = 0, Au = A0u = 0, Av = A0v = 0:
Then (S0 , I 0 , A0u , A0v , R0u , R0v , D0 ,V 0 ) = (S0 , 0, 0, 0, 0, 0, 0,V 0 ) since S0 +V 0 = 1 = N.
Note that two cases were considered:
(i) If the daily vaccination rate ν = 0 then S0 and V 0 are some constant portion of the
population since, without daily vaccinations, there is no travel between susceptible and
vaccinated compartments. In addition, no vaccine control measure existed when the first
infected case occurs in Mississippi; therefore, there are no vaccinated individuals and
V 0 = 0.
(ii) If the daily vaccination rate ν ̸= 0 then all susceptible individuals eventually travel to V 0
at the disease-free equilibrium, and eventually there are no susceptible individuals, making
S0 = 0.
The daily vaccination rate ν can then be observed for the population of Mississippi
within different scenarios. Since the first vaccine administration was on December 14, 2020,
we assumed that some portion of the susceptible population is vaccinated by the time the
Delta variant became the major variant in Mississippi on June 16, 2021 [21]. At this
equilibrium point, we assumed that while the entire population was susceptible, some of the
population may have received a vaccine. Since at this disease-free equilibrium point
N(t0 ) = S0 +V 0 , then S0 = N(t0 ) −V 0 where N(t0 ) is the initial population size, providing
an equilibrium point of:
(N(t0 ) −V 0 , 0, 0, 0, 0, 0, 0,V 0 ) = (S0 , 0, 0, 0, 0, 0, 0,V 0 ).
This system represents an epidemic model which was used to observe the rapid
outbreak of COVID-19 in Mississippi and does not observe population dynamics such as
natural births and deaths in the population. Then the system does not have any
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endemic-equilibrium points since the population is at a constant state and we cannot
observe the disease with constant prevalence [5]. System (1) has an infinite number of
disease-free equilibrium points since all populations stay within the system and the
population stays constant, where at the disease-free equilibrium point, S and V can be any
portion of the population. Therefore, we chose (S0 , 0, 0, 0, 0, 0, 0,V 0 ) as our disease-free
equilibrium point.

Reproduction Number
The reproduction number of the system is defined as the number of cases expected to
stem from one infected case in a susceptible population. The reproduction number for the
system was found using the next-generation matrix method by finding the spectral radius of
the Jacobian matrix for the infected compartments I ′ , A′u , A′v at the disease-free equilibrium
[6]. Entries of matrix F represent new infections from those infected individuals. Entries of
matrix G represent the outflow of infected compartments into other compartments such as
recovered or deceased. Then,



ξ αI SI + ξ SαA Au + ξ SαA Av
F =  (1 − ξ )SαI I + (1 − ξ )SαA Au + (1 − ξ )SαA Av 
(1 − τ)V αI I + (1 − τ)V αA Au + (1 − τ)V αA Av


I(ρs + µ)
G =  ρau Au 
ρav Av

Then the Jacobian matrices for F and G are as follows:


ξ S0 αI
ξ S 0 αA
ξ S 0 αA
F ′ =  (1 − ξ )S0 αI (1 − ξ )S0 αA (1 − ξ )S0 αA 
(1 − τ)V 0 αI (1 − τ)V 0 αA (1 − τ)V 0 αA


(ρs + µ) 0
0
ρau 0 
G′ =  0
0
0 ρav
The inverse of the matrix G′ :


(G′ )−1 = 

1
(ρs +µ)

0
0
13

0
1
ρau

0


0

0

1
ρav

The next-generation matrix for system (1) at the disease-free equilibrium:

 ξ S0 α
ξ S0 α
ξ S0 α
I

A

(ρs +µ)
 (1−ξ
)S0 αI
′
′ −1

F (G ) =  (ρ +µ)
s
(1−τ)V 0 αI
(ρs +µ)

A

ρau
(1−ξ )S0 αA
ρau
(1−τ)V 0 αA
ρau

ρav

(1−ξ )S0 αA 
ρav

(1−τ)V 0 αA
ρav

The reproduction number was found from the largest eigenvalue of F ′ (G′ )−1 .
ξ S0 αI
−λ
s +µ)
 (ρ(1−ξ
0α
)S
′
′ −1
I
det(F (G ) − λ I) = det 
 (ρs +µ)
(1−τ)V 0 αI
(ρs +µ)




=

ξ S0 αI
−λ
(ρs + µ)

(1−ξ )S0 αA
−λ
ρau
(1−τ)V 0 αA
ρau



ξ S 0 αA
ρau
(1−ξ )S0 αA
−λ
ρau
(1−τ)V 0 αA
ρau

(1−ξ )S0 αA
ρav
(1−τ)V 0 αA
−λ
ρav

ξ S0 αA
−
ρau


ξ S 0 αA
+
ρav




ξ S0 αA
ρav

(1−ξ )S0 αA 
ρav

(1−τ)V 0 αA
−λ
ρav





(1−ξ )S0 αI
(ρs +µ)
(1−τ)V 0 αI
(ρs +µ)

(1−ξ )S0 αI
(ρs +µ)
(1−τ)V 0 αI
(ρs +µ)

(1−ξ )S0 αA
ρav
(1−τ)V 0 αA
−λ
ρav

(1−ξ )S0 αA
−λ
ρau
0
(1−τ)V αA
ρau


(1 − ξ )S0 αA (1 − τ)V 0 αA
ξ S 0 αI
−λ
=
(ρs + µ)
ρau ρav



0
(1 − ξ )S0 αA (1 − τ)V 0 αA
(1 − ξ )S αA (1 − τ)V 0 αA
2
+λ −
−λ
+
ρau
ρav
ρav ρau
 0 

0
0
0
ξ S αA
(1 − ξ )S αI (1 − τ)V αA
(1 − ξ )S αI (1 − ξ )S0 αA (1 − τ)V 0 αI
−
−λ
−
ρau
(ρs + µ)ρav
ρs + µ
ρav (ρs + µ)
 0 

0
0
0
0
ξ S αA
(1 − ξ )S αI (1 − τ)V αA (1 − ξ )S αA (1 − τ)V αI
(1 − τ)V 0 αI
+
−
+λ
ρav
(ρs + µ)ρau
(ρs + µ)ρau
ρs + µ


= −λ

2



(1 − ξ )S0 αA (1 − τ)V 0 αA
ξ S 0 αI
+
+
−λ
ρau
ρav
(ρs + µ)



Then the reproduction number of the system is

R0 =

(1 − ξ )S0 αA (1 − τ)V 0 αA
ξ S 0 αI
+
+
ρau
ρav
(ρs + µ)

(4)

which is the sum of the secondary infections caused by those asymptomatic susceptible,
vaccinated, and symptomatic susceptible.
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Remark III.3.1. If ν ̸= 0 then S0 eventually becomes 0 and the basic reproduction number
becomes the effective reproduction number
Re =

(1 − τ)V 0 αA
ρav

since the susceptible population is now vaccinated and therefore immune except for
breakthrough cases. Thus Re will depend on vaccine effectiveness τ. This assumption
depicts how effective the vaccine must be to produce the smallest effective reproduction
number feasible for COVID-19 in Mississippi.

Linear Stability Analysis
Theorem III.4.1. Let (S0 , 0, 0, 0, 0, 0, 0,V 0 ) be a disease-free equilibrium. Then the
ASIRD −V system is locally asymptotically stable if the basic reproduction number
R0 < 1. Conversely, the system is locally unstable if the basic reproduction number R0 > 1.
Proof:
At the disease-free equilibrium, we determined the Jacobian matrix of the ASIRD −V
system:
0
−S0 αI
−S0 αA
−S0 αA
0 −(ρ +µ)
0
0
ξ
α
S
ξ
α
S
ξ αA S 0
s
I
A

 0 (1−ξ )αI S0 (1−ξ )αA S0 −ρau (1−ξ )αA S0

0
αI (1−τ)V 0
αA (1−τ)V 0 αA (1−τ)V 0 −ρav
J0 = 
 0
ρs
ρau
0
 0
0
0
ρav

0
µ
0
0
0S0 αI (1−τ)V 0
αA (1−τ)V 0
αA (1−τ)V 0



0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0

−λ
−S0 αI
−S0 αA
−S0 αA
0
0
ξ αA S
ξ αA S 0
 0 ξ αI S −(ρs +µ)−λ
0
0
 0
(1−ξ )αI S
(1−ξ )αA S −ρau −λ
(1−ξ )αA S0
 0
0
0
αI (1−τ)V
αA (1−τ)V
αA (1−τ)V 0 −ρav −λ
(J0 − λ I) = 
 0
ρs
ρau
0
 0
0
0
ρ
av

0
µ
0
0
0
αI (1−τ)V 0
αA (1−τ)V 0
αA (1−τ)V 0



15

0
0
0
0
0
0
0
0



0
0
0

0
0

0
0
0

0
0
0
0
−λ
0
0
0

0
0
0
0
0
−λ
0
0

0
0
0
0
0
0
−λ
0



0
0 
0 

0 
0 

0 
0
−λ

Calculating the characteristic polynomial of the Jacobian matrix presented the equation
det(J0 −λ I) = −λ [(ξ αI S0 −(ρs + µ)−λ )[((1−ξ )αA S0 −ρau −λ )(αA (1−τ)V 0 −ρav −λ )λ 4
− (1 − ξ )αA S0 (αA (1 − τ)V 0 )λ 4 ]
− ξ αA S0 [(1 − ξ )αI S0 (αA (1 − τ)V 0 − ρav − λ )λ 4 − (1 − ξ )αA S0 (αI (1 − τ)V 0 )λ 4 ]
+ ξ αA S0 [(1 − ξ )αI S0 (αA (1 − τ)V 0 )λ 4 − ((1 − ξ )αA S0 − ρau − λ )(αI (1 − τ)V 0 )λ 4 ]]
which is equivalent to
− λ 5 [(ξ αI S0 − (ρs + µ) − λ )[λ 2 + λ (ρau + ρav − (1 − ξ )αA S0 − αA (1 − τ)V 0 )
− (1 − ξ )αA S0 ρav − ρau αA (1 − τ)V 0 + ρau ρav ]
+ ξ αA S0 [(1 − ξ )αI S0 (ρav + λ ) + (αI (1 − τ)V 0 )(ρau + λ )]].
Reducing and substituting the reproduction number provided the following eighth order
characteristic polynomial:
λ 5 [λ 3 − λ 2 (ξ αI S0 − (ρs + µ) − ρau − ρav + (1 − ξ )αA S0 + αA (1 − τ)V 0 )
− λ (ξ αI S0 (ρav + ρau ) − (ρs + µ)(ρav + ρau − (1 − ξ )αA S0 − αA (1 − τ)V 0 )
+ (1 − ξ )αA S0 ρav + αA (1 − τ)V 0 ρau − ρau ρav )
+ (ρs + µ)ρau ρav (1 − R0 )].
We used the Routh-Hurwitz stability criterion on the third order polynomial
λ 3 − λ 2 (ξ αI S0 − (ρs + µ) − ρau − ρav + (1 − ξ )αA S0 + αA (1 − τ)V 0 )
− λ (ξ αI S0 (ρav + ρau ) − (ρs + µ)(ρav + ρau − (1 − ξ )αA S0 − αA (1 − τ)V 0 )
+ (1 − ξ )αA S0 ρav + αA (1 − τ)V 0 ρau − ρau ρav )
+ (ρs + µ)ρau ρav (1 − R0 )
which can be shaped as
λ 3 − a2 λ 2 − a1 λ + a0

16

where
a2 = −(ξ αI S0 − (ρs + µ) − ρau − ρav + (1 − ξ )αA S0 + αA (1 − τ)V 0 )

a1 = −(ξ αI S0 (ρav + ρau ) − (ρs + µ)(ρav + ρau − (1 − ξ )αA S0 − αA (1 − τ)V 0 )
+ (1 − ξ )αA S0 ρav + αA (1 − τ)V 0 ρau − ρau ρav )
a0 = (ρs + µ)ρau ρav (1 − R0 )
to determine that the polynomial is stable and the system has control of the disease if and
only if (i) coefficients a2 and a0 are positive and (ii) a2 a1 > a0 [14]. Note that
ξ , αI , αA , ρs , µ, ρav , ρau , τ, (1 − ξ ), (1 − τ), S0 ,V 0 > 0.
(i) Let R0 be defined as equation (4) and R0 < 1. Then 1 − R0 > 0. Since
(ρs + µ)ρauρav > 0 and (1 − R0 ) > 0, then a0 = (ρs + µ)ρau ρav (1 − R0 ) > 0. Similarly,
if R0 < 1 then 0 <

(1−ξ )S0 αA
ρau

< 1, 0 <

(1−τ)V 0 αA
ρav

< 1, and 0 <

ξ S0 αI
(ρs +µ)

< 1. Rearranging,







(1 − ξ )S0 αA
(1 − τ)V 0 αA
ξ S 0 αI
a2 = ρau 1 −
+ ρav 1 −
+ (ρs + µ) 1 −
ρau
ρav
(ρs + µ)
h
i
h
i
h
i
(1−ξ )S0 αA
(1−τ)V 0 αA
ξ S 0 αI
Then 1 −
> 0, 1 −
> 0, and 1 − (ρs +µ) > 0. Since
ρau
ρav

(5)

ρau > 0, ρav > 0 and (ρs + µ) > 0, then a2 > 0.
Therefore, if R0 < 1, then a2 > 0 and a0 > 0.
(ii) Let R0 be defined as equation (4) and R0 < 1. From (i), we have a2 > 0 and a0 > 0. We
(1−ξ )S0 αA
(1−τ)V 0 αA
<
1,
0
<
< 1, and
ρau
ρav
0
0
(1−ξ )S αA
αA
+ (1−τ)V
< 1 Using equation (5),
ρau
ρav

also have 0 <
0<

0<

ξ S 0 αI
(ρs +µ)

< 1. In addition,

a2 a1 − a0 =





ξ S 0 αI
0
0
a2 (ρs + µ) (ρau + ρav ) 1 −
− (1 − ξ )αA S − (1 − τ)αA S
(ρs + µ)


 



ξ S 0 αA
(1 − ξ )S0 αA (1 − τ)S0 αA
+ a2 − (ρs + µ) 1 −
ρau ρav 1 −
+
(ρs + µ)
ρau
(ρav


ξ S 0 αI
(1 − ξ )S0 αA (1 − τ)V 0 αA
+
+
(ρs + µ)
ρau
ρav
Then a2 a1 − a0 > 0 if R0 < 1.
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Then by (i) and (ii), the system is stable when R0 < 1 and unstable when R0 > 1.
Now, we proved that our model can simulate the spread of COVID-19 as well as the
vaccine administration in Mississippi with realistic numbers. With nonnegative and
bounded solutions, no compartment in our model can have negative population values. In
addition, our model is endemic, meaning we defined (S0 , 0, 0, 0, 0, 0, 0,V 0 ) as our
disease-free equilibrium since we were not observing a constant prevalence in short-time
periods. The basic reproduction number R0 of our system is derived from all infectious
compartments, and we determined the stability of the system in relation to this number.
In the next chapter, we applied our ASIRD −V model to four different time periods of
the COVID-19 pandemic in Mississippi. Two of these observations occurred before vaccine
development while two explored observations during active vaccine administration in
Mississippi. We used the mathematical programming language MATLAB to numerically
solve our system with parameters optimized to death and vaccine data downloaded from the
CDC. Since the vaccine efficacy τ is given by the CDC, we optimized eight out of nine
parameters using the sum of least squares method. By minimizing the difference between
the solutions D and V against the death and vaccine data, the sum of least squares objective
function computed the best parameter values to model the spread of COVID-19 and vaccine
administration. We have a list of eight unknown nonnegative parameters
p = (αI , αA , ρs , ρau , ρav , ν, µ, ξ ) optimized for each time period t from k to K days where
DMS (tk ) is the cumulative total confirmed deaths data on the kth day and VMS (tk ) is the
cumulative vaccine data on the kth day. Both data sets were scaled to 1. Then the following
function was minimized:
v "
uK 
2 
2 #
u
D
(t
)
V
(t
)
MS k
MS k
L(p) = t ∑
− D(tk ; p) +
−V (tk ; p)
6
2.96
×
10
2.96
× 106
k=1

(6)

We wanted to observe how well our model could simulate and predict these time periods
and understand how this disease spread among Mississippians.
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CHAPTER IV: RESULTS
In this study, we applied the ASIRD −V system to simulate the spread of COVID-19 in
Mississippi for four time periods, separated into periods with and without vaccine
administration. The first two time periods spanned 32 days from the first confirmed case of
COVID-19 in Mississippi on March 4, 2020 to April 4, 2020. In these two time spans, we
used only death data from the CDC in optimizing our parameters using the sum of least
squares method [13]. For the first time span, the initial condition for infected I(0) used
confirmed cases data on March 4. Since there was no data on the initial number of
asymptomatic cases, or any data on asymptomatic cases, the initial condition for
unvaccinated asymptomatic cases Au (0) was estimated and not verifiable. The second time
span is a continuation of the first time span, starting on March 23, 2020 where the
parameters were observed to need re-optimization. Therefore, the initial conditions for
March 23, 2020 to April 4, 2020 are the values given by the ASIRD −V model on March
23, 2020 using the parameters optimized in the first time span. The next two time periods
used only the death data and the vaccine data given by the CDC to optimize parameters
using the sum of least squares method [13] [12]. These two time spans were further within
the timeline of the pandemic, and since the exact number of infected individuals on a
particular day is difficult to obtain and verify, the initial number of infected individuals was
included in the model as a parameter to be estimated, which can be used to check the
validity of the model. However, the fourth time period clearly shows this decision must be
revised for any future research.

Without Vaccine Administration
The first 20 days of the pandemic in Mississippi were modeled with parameters
optimized from March 4, 2020 to March 23, 2020. An additional three days were predicted
using these optimized parameters to verify any changes that occur. The following initial
conditions were used:
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4
= 1.35 × 10−6 Au (0) = 1.24 × 10−6
2960000
Ru (0) = 0 Rv (0) = 0 D(0) = 0 V (0) = 0
I(0) =

Av (0) = 0
(7)

S(0) = 1 − (I(0) + Au (0))
where I(0) is the initial number of confirmed cases on March 4, 2020, divided by the total
population of Mississippi, and Au (0) was found through trial and error for a realistic model
with reasonable numbers, landing at about 3 unvaccinated asymptomatic individuals. Note
that the initial condition for asymptomatic individuals is not verifiable since no data for
asymptomatic cases were collected for Mississippi. The initial susceptible population S(0)
is 1 minus the sum of the infected symptomatic and asymptomatic since the rest of the
compartments do not yet contain any individuals. To observe the effect of the changes in
health policies during the pandemic without a vaccine, the necessary parameters of the
model were optimized with death data from March 4, 2020 to March 23, 2020 using the
sum of least squares method. Since during this time there were no vaccines, optimization of
the parameters ρav = 0 and ν = 0 was not necessary. These parameter values made the
model identical to the ASIRD model since V , Av , and Rv were valued at 0 for this time. The
parameter values were used to predict the next 3 days when Mississippi Governor Tate
Reeves passed the MS Executive Order 1463: Stay at Home from March 24, 2020 to April
17, 2020 [22]. The parameters were optimized to the following values:

αI = 0.00587 αA = 1.62 ξ = 0.773

ρs = 0.00979 ρau = 0.289

µ = 0.0981 (8)

In the numerical solution of the system, we computed the reproduction number R0 to be
approximately 1.32. Since this value is greater than 1, we observed an epidemic of
COVID-19 in Mississippi. The parameter values for these figures were also reasonable for
the reality of the pandemic. The asymptomatic infection rate αA was greater than the
symptomatic infection rate αI while the unvaccinated asymptomatic recovery rate ρau was
greater than the symptomatic recovery rate ρs . Since there were so few symptomatic
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Figure 2: Solution of Susceptible Population from March 4 to March 26, 2020
Parameters are optimized to the following values:
αI = 0.00587, αA = 1.62, ξ = 0.773, ρs = 0.00979, ρau = 0.289, µ = 0.0981. Additionally,
ρav = 0, ν = 0, τ = 0 and R0 = 1.32

Figure 3: I, Au , Av , Ru , Rv , D from March 4 to March 26, 2020
Since there is no vaccine at this time, Av = Rv = 0 for all 23 days
infected, it is reasonable to see that the rate of infection for symptomatic individuals was
small. In addition, it was reasonable to assume that at the beginning of the pandemic, there
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Figure 4: Data fitting for D from March 4 to March 23, 2020
This graph is using the first 20 days of death data by the Centers for Disease Control [13]
and predicts March 24 to March 26, 2020 with optimized parameters.
were individuals who had COVID-19 who showed few symptoms or simply were not tested
for this disease because of the lack of testing and knowledge. Thus these individuals spread
the disease faster since they were not quarantined or did not observe the necessary health
protocols for infected individuals. However, since the number of asymptomatic individuals
is unknown and cannot be verified by data, these values for asymptomatic individuals
should not be considered accurate. The recovery rates reflect how treatment for
symptomatically infected individuals was new and lacked the resources and knowledge of
the symptoms of COVID-19 while individuals with little to no symptoms recovered faster
than those with severe symptoms. Figures 2 and 3 show the COVID-19 epidemic with the
reproduction number R0 = 1.32. In figure 2, as more people became infected, the
susceptible population decreased. In figure 3, as the disease spread among the susceptible
population, more people became infected and either recovered or died. Finally, Figure 4
shows the impact of restricting group sizes in the population as well as social-distancing
measures and wearing masks as a preventative against the spread of COVID-19. Near the
day of the Executive Stay at Home Order, the system no longer reflected the deceased
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number of individuals as verifiable by the CDC death data. This change indicates some
effect of the Stay at Home Order, and the optimized parameters no longer represent the
spread of COVID-19 in Mississippi. Thus, the next time period of the pandemic required
the parameters to be re-optimized to account for the reaction of the population.
Beginning on the day of the Stay at Home Executive Order, the time period March 23,
2020 to April 4, 2020 was modeled with parameters optimized for the period March 23 to
April 1, 2020. On April 1, 2020, Mississippi Governor Tate Reeves passed Executive Order
1466 which closed all nonessential businesses [22]. The next day, the CDC officially
recommended the use of masks and social distancing to prevent the spread of COVID-19.
Since this time represents nearly the beginning of the pandemic, initial conditions for the
vaccinated and its subsequent infected and recovered populations were assumed to be 0.
The following are the initial conditions computed by the previous model with parameters
values of (8) on March 23:
I(0) = 4.132 × 10−5
Ru (0) = 2.051 × 10−5

Au (0) = 6.4555 × 10−6
Rv (0) = 0

Av (0) = 0

D(0) = 2.905 × 10−5 V (0) = 0

(9)

S(0) = 1 − (I(0) + Au (0) + Ru (0) + D(0))
The initial numbers of symptomatic I(0), unvaccinated asymptomatic Au (0), and
unvaccinated recovered Ru (0) were determined by their values on March 23 as observed
with the previously optimized parameters (8), approximately 122, 19, and 70 individuals
respectively. The initial number of deaths D(0) was determined by the cumulative death
data given by the CDC for March 23. Again, since there was no vaccine during this time,
Av (0) = Rv (0) = V (0) = 0, and we optimized the system identical to the ASIRD model.
The parameters were optimized to the following values:
αI = 0.9646

αA = 0.3328 ξ = 0.1538

ρs = 0.2889

ρau = 0.1225

(10)
µ = 0.07644

Figures 5, 6, and 7 depict the effects of the population following these changes in
health policies. Firstly, the basic reproduction number R0 = 2.705 signified that people
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were infecting more people than before, showing the infectiousness of this disease and
continuing the epidemic. The parameter values optimized to the death data were also shown
to be reasonable for this time in the pandemic. The symptomatic infection rate αI was now
greater than the asymptomatic infection rate αA while the symptomatic recovery rate ρs
grew to be greater than the asymptomatic recovery rate ρau . Figure 5 shows the susceptible
population decreased as individuals became either symptomatic or asymptomatic, and
Figure 6 shows the spread of COVID-19 as more people became aware of its persistence,
with the last three days predicted. As more people become symptomatically infected, the
larger the rate of symptomatic infection becomes. Similarly, an asymptomatic individual
either does not realize they have the disease or shows such few symptoms as not to isolate
themselves and thus infect a significant amount of the population. By this time, the number
of deaths was low, reflecting the time before the overcrowding of hospitals and the lack of
ventilators.

Figure 5: S from March 23 to April 4, 2020
Figure 7 depicts the changes when individuals began applying health protocols and
following strict guidelines recommended by the Centers for Disease Control in Mississippi.
The data fit well for this time period; however, when the parameters (10) were used to
predict the next few days, the system was no longer accurate when verified with the death
data. The difference between the model and the data shows the lives that were saved while
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Figure 6: I, Au , Av , Ru , Rv , D from March 23 to April 4, 2020
Here, αI = 0.9646, αA = 0.3328, ξ = 0.1538, ρs = 0.2889, ρau = 0.1225, µ = 0.07644
Additionally, R0 = 2.705. Since there is no vaccine at this time, Av = Rv = 0.

Figure 7: Data fitting for D, from March 23 to April 1, 2020
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the executive order shut down bars, restaurants, and schools, as well as wearing a mask as
recommended by the CDC. After April 1, the system was no longer a good model with the
current optimized parameters (10). Due to the reactions to policies and more proactive
health guidelines, the parameters required re-optimization for any subsequent time periods.

With Vaccine Administration
The first dose of the vaccine available in Mississippi was the Pfizer vaccine on
December 16, 2020. By this time, only those 65 years and older and those with underlying
health problems were eligible to receive the vaccine. Additionally, two doses of the Pfizer
or Moderna mRNA vaccines are required to become fully vaccinated; the second dose of
Moderna is given 28 days after the first and the second dose of Pfizer is given 21 days after
the first. Between the first and second doses, both mRNA vaccines have effectiveness
between 40 and 80 percent at preventing the contraction of COVID-19 [18]. The Janssen
vaccine only requires one dose, and studies have shown its effectiveness at prevention to be
approximately 69% [20].
The ASIRD-V model was used to observe the effects of disease prevention with a
vaccine. To observe the effect of distributing vaccines to Mississippians, the first week of
vaccine administration was modeled with optimized parameters; these parameters were then
used to predict the next five days in comparison to the data provided by the CDC. The only
two initial conditions that are verifiable and accurate are the initial deceased D(0) and the
initial vaccinated with one dose V (0). There was no data available to tell us exactly how
many people were currently infected with COVID-19 in Mississippi; although the value can
be estimated with confirmed cases data, the exact initial number of infected I(0) on a
particular day cannot be determined accurately by confirmed cases. Instead, we
approximated I(0) with the number of confirmed cases, although not exactly the number of
cumulative confirmed cases from the past two weeks. Since we modeled the pandemic
without modeling all previous time periods, the initial conditions were approximated to the
best possible values to obtain reasonable parameters. Therefore, the solutions to the system
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for this time period do not represent an accurate depiction of the spread of COVID-19 in
Mississippi. To optimize the parameters from December 16, 2020 to December 22, 2020,
the following initial conditions were used:

I(0) = 0.0075433 Au (0) = 0.0075909 Av (0) = 3.38 × 10−7
Rv (0) = 0

Ru (0) = 0.075115

D(0) = 0.0016928 V (0) = 1.6885 × 10−6

S(0) = 1 − (I(0) + Au (0) + Av (0) + Ru (0) + Rv (0) + D(0) +V (0))
(11)
The initial number of symptomatic infected I(0) was determined by an estimated
number of cases in Mississippi according to CDC new cases data for December 16,
approximately 22,330 infected individuals. The initial number of unvaccinated
asymptomatic Au (0) was determined through trial and error in finding a realistic model with
reasonable parameters and accounts for approximately 22,470 individuals. The initial
condition for Av (0) was assumed and represents one person who became infected after
receiving only one dose of the vaccine. Since the initial condition started on the first day of
vaccine administration, we assumed there were no initial individuals vaccinated and
recovered from the disease. By using the CDC data on vaccinations, we assumed the first
week of vaccinations composed of only first dose mRNA vaccines, with initially only 5
individuals vaccinated [12]. Additionally, since the Janssen vaccine was not administered
during the first week, the vaccine effectiveness (τ) of only one dose for both mRNA
vaccines was assumed to be 89%.
Lastly, we again used the CDC deaths data on December 16 to determine the initial
number of deceased individuals. By using both vaccine data and death data from the CDC,
the parameters were optimized to the following values:
αI = 0.05093 αA = 0.001625

ξ = 0.05124 ρs = 0

ρau = 0.04999 ρav = 1.75038 × 10−10

(12)
µ = 0.001695

ν = 0.0002026

Figures 8 through 14 depict the compartments of the system as COVID-19 spread rapidly
with a calculated reproduction number R0 = 3.15 and a prediction of the last five days.
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Figure 8: Data fitting for D, from December 16 to December 22, 2020

Figure 9: Data fitting for V from December 16 to December 22, 2020
From Figures 8 and 9, the first dose of vaccine administration has little to no effect on the
number of rising deaths caused by COVID-19 during this time. Figure 10 shows that as the
vaccine administration began and the epidemic continued, very few people within the
susceptible population moved to the vaccinated population. The vaccine data shows the
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Figure 10: S from December 16 to December 22, 2020

Figure 11: I and Au from December 16 to December 22, 2020.
jump in vaccine administration at the end of the first week. The vaccine rollout plan,
although targeted toward the higher-risk population, meant a longer wait until more
vaccines became available. Those with underlying health conditions, people aged 65 and
above, and first responders who received the vaccine during this time resulted in a slower
vaccine administration in the first week. Although this helped the portion of susceptible
people located in long-term care facilities, there was no significant effect on the susceptible
population as a whole since the benefits of vaccination for the entire population could be
reached with such a small vaccinated population [18]. Figure 11 shows the symptomatic
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Figure 12: Ru , December 16 to December 22, 2020

Figure 13: Av from December 16 to December 22, 2020
This population accounts for those infected but received one dose of a vaccine.
infected population increased and the unvaccinated asymptomatic population decreased.
Meanwhile, the unvaccinated recovered population continued to steadily grow as
individuals recovered from the disease.
From Figures 13 and 14, those infected with one dose of the vaccine were not
recovering within one week, resulting in a significantly smaller Rv population which can be
regarded as 0. Due to the lower vaccine efficacy of an incomplete vaccine series, some
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Figure 14: Rv from December 16 to December 22, 2020
breakthrough infections occurred within the vaccinated population. While the vaccinated
population is still very small during this time, Figure 13 shows the steady but small increase
in the vaccinated asymptomatic population with only one dose.
As with the previously observed time periods, the changes and reactions of the
populations following the first week of vaccine administration caused the model to lose
accuracy in the prediction of the next five days. The model required re-optimized
parameters to account for these changes in the observed time periods.
One very interesting discovery from this set of parameters and initial conditions was the
decrease of the unvaccinated asymptomatic population Au . Figure 11 shows how, although
the number of infected I was still slowly increasing, there was a drastic decrease in those
with little to no symptoms. Since almost no data on the asymptomatic population exists, it is
difficult to say if this is an accurate representation of the asymptomatic population.
Similarly, the time March 6, 2021 to March 20, 2021 was modeled with optimized
parameters for 11 days from March 6, 2021 to March 16, 2021. Nearly a year after the first
COVID-19 case in Mississippi and only a few months after the first vaccine administration,
approximately 8% of the population was fully vaccinated. The data used to optimize the
vaccination rate was collected from the CDC data on the total number of fully vaccinated
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people [12]. The first collection of this data started on March 6, 2021. Similar to the time
period with one dose of vaccines, the only initial conditions that are verifiable and accurate
are the number of initial deceased individuals D(0) and the number of initial fully
vaccinated individuals V (0). As a weakness of our model, the number of initially infected
individuals had to be approximated and assumed to obtain reasonable parameters. For this
time period, we did not use the confirmed cases to approximate I(0) and instead included
the value as a parameter to be optimized. This choice was made because of the model’s
weakness of using only the death and vaccine data since the model does not have a
parameter to utilize other data sets such as confirmed cases. After some difficulty in
approximating the initial conditions for the infected and recovered, the following initial
conditions were used to optimize the parameters for this time period:
I(0) = 0.07416 Au (0) = 0.0999 Av (0) = 0.02 × I(0)
D(0) = 2.38817 × 10−3

Ru (0) = 0.09708 Rv (0) = 0
(13)

V (0) = 0.08512
S(0) = 1 − (I(0) + Au (0) + Av (0) + Ru (0) + Rv (0) + D(0) +V (0))
The earliest recording from MDHS of cases coming from vaccinated individuals started
in June. According to the MDHS, about 2% of cases came from those who were fully
vaccinated for June, so we assumed the initial number of vaccinated but infected was 2% of
the infected population on March 6, 2021. We expected to observe a change on March 16,
2021, when people ages 16 and above became eligible for the vaccine. The vaccine efficacy
rate against the first major variant in the pandemic was established to be about 97% for
those who are fully vaccinated, so τ = 0.97 [18]. The parameters were optimized to the
following values:
αI = 0.8334

αA = 0.09796 ξ = 0.000016

ρs = 0.1183

ρAu = 0.10535 ρAv = 0.000134

µ = 0.000047

(14)

ν = 0.007118

Figures 15 through 21 display the spread of COVID-19 in Mississippi, albeit slower
than the previously observed time period as the reproduction number was approximately
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Figure 15: S from March 6 to March 24, 2021

Figure 16: I and Au from March 6 to March 24, 2021
In this figure, the number of infected is unrealistic by CDC data on confirmed cases.
2.45. Additionally, we predicted the last five days of this time period with the optimized
parameters. These figures show unrealistic responses as verified by the CDC data on the
daily confirmed cases. Figure 15 shows a drastic and unrealistic decline in the susceptible
population while Figure 16 shows a high number of unvaccinated infected individuals,
which stemmed from the unrealistic initial infected value calculated by optimization as a
parameter. While those infected with symptoms decreased in number gradually throughout
time, the unvaccinated asymptomatic population increased until a certain point and then
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Figure 17: Ru from March 6 to March 24, 2021

Figure 18: Av from March 6 to March 24, 2021
decreased afterward for the rest of the twenty days. Since no data on the asymptomatic
individuals was available due to a lack of testing and reporting, the Au curve should not be
considered accurate. Meanwhile, Figure 17 shows the drastic recovery of those who had
been infected without being fully vaccinated. The vaccinated asymptomatic population was
observed to increase from approximately 44,400 individuals to 118,000 individuals in 20
days.
Figures 20 and 21 show the parameter optimization for fully vaccinated individuals and
deceased individuals respectively. While not a perfect fit, the vaccine compartment in
Figure 20 shows the population size of fully vaccinated individuals did not meet the
expectations of the model in twenty days with parameters optimized for the first 11 days. At
34

Figure 19: Rv from March 6 to March 24, 2021

Figure 20: Data fitting V from March 6 to March 24, 2021
approximately March 16, the model no longer accurately represented the vaccine
administration and deceased population in Mississippi. However, the data for vaccine
administration was less than what the model predicted; with an expanse in eligible
vaccinations, we would have expected the data to have values greater than the model
predicted. However, since this change may be more gradual than anticipated, an expansion
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Figure 21: Data fitting for D from March 6 to March 24, 2021
of this time period would need to be optimized and simulated. Similarly, Figure 21 shows
the data on deceased individuals did not agree with the predictions of the model for twenty
days with parameters optimized for only 11 days. The lower vaccination rate was reflected
in the death rate with an unexpected distance between the data values and the model values
beginning after the tenth day observed for this period. We contemplated the possible
reasons behind these unexpected changes in the next section. Lastly, since this time period
has shown such unrealistic numbers of infected and recovered individuals, we do not claim
these Figures represent the path of the pandemic in Mississippi during this time.
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CHAPTER V: CONCLUSION
In this study, we developed a simple epidemiological model to simulate the spread of
COVID-19 in Mississippi with and without vaccinations. Due to the numerous changes in
health policies and mandates that were declared as COVID-19 developed in Mississippi, our
model created simulations for short periods of time. The daily confirmed case numbers,
cumulative deceased, and cumulative vaccinated data were used to provide optimized
parameters for these time periods; as seen in our results, these parameters in the model
could not be accurately predicted without re-optimization for the next time period. In
addition, a weakness of our model appeared when simulating for time periods further into
the pandemic. Despite these shortcomings, we observed the effects of different health
policies on the spread of COVID-19 in Mississippi by the changes that occurred between
the model predictions and the available death and vaccine data.
Our results have shown interesting parameter values as well as some unexpected
developments. During the period without the vaccine, March 4 to April 4, 2020, Figures 2
through 7 show the increased spread of COVID-19 in the population of Mississippi. The
reproduction number R0 in the model increased from 1.35 to 2.7 during this time, as well as
the symptomatic infection rate αI from 0.00587 to 0.9646. Despite these increases, the
strict health policies placed by Governor Tate Reeves helped decrease the death rate µ from
0.0981 to 0.0764 between March 4 to March 23 and March 23 to April 4. Although the
deaths were still increasing, the rate of deaths is observed to slow when comparing Figure 4
and Figure 7, where the optimized parameters forecasted more deaths than what the data
shows. The asymptomatic infection rate αA also decreased from 1.62 to 0.3328 between
these two time periods. The dramatic increase of asymptomatic individuals Au is likely
observed due to the probability of becoming asymptomatic (1 − ξ ) increasing from 0.227 to
0.8462 between these two time periods. This could be caused by the increased
infectiousness of the disease as well as the lack of testing in general. A lack of testing
would increase the uncertainty that those who only show mild symptoms would not report
or be tested. This uncertainty included in our model helped us understand the increase of
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the basic reproduction number R0 and the decrease in the death rate µ.
Since we do not have available data on the number of asymptomatic cases, our
conclusion should not be considered entirely accurate. In addition to those health policies,
the decrease in the death rate and the asymptomatic infection rate was likely caused by the
increased awareness of the disease, better information on treatments of the disease, and the
number of individuals following health protocols.
In March of 2020, pharmaceutical companies Pfizer and BioNTech began the rapid
development of COVID-19 vaccines; within nine months, vaccines were ready to be
administered to the public. Two mRNA vaccines, Pfizer and Moderna, require two doses to
be considered fully vaccinated at about 90% efficacy [17]. The Janssen vaccine requires one
dose, but it is less effective than the mRNA vaccines, reporting only 66% efficacy two
weeks after vaccination [20]. In this study, we observed the time of the first week of vaccine
administration in Mississippi, December 16 to December 22, 2020, and the time of the first
data available for fully vaccinated individuals, March 6 to March 24, 2021. Note that in the
first week of vaccine administration observed, Janssen vaccines were not administered. Our
results showed insightful parameter values and simulated, with predictions, the pandemic in
Mississippi with vaccine administration.
Figures 8 through 21 show how vaccine administration was more gradual at preventing
infection of COVID-19 in Mississippi than other preventions such as the Stay at Home
order or mask mandates by observing the differences in the vaccine and death data and the
solutions for compartments that the system computed. Despite the unrealistic responses as
seen in the last time period observed, we observed the effects of different policies on the
population. The reproduction number R0 in the model decreased from 3.15 to 2.45, and the
death rate µ decreased from 0.001695 to 0.00005 between these two time periods. Despite
these decreases, both the symptomatic infection rate αI and the asymptomatic infection rate
αA increased from 0.0509 and 0.001625 to 0.8335 and 0.0979, respectively. This could be
due to the high infectiousness of the disease while the vaccines were being administered,
and it is not until individuals were becoming fully vaccinated that we observed a decrease in
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the reproduction number. Note that the first observation of vaccine administration is the first
week of vaccine administration in Mississippi. The low recovery rates were likely explained
by people with severe symptoms not recovering within one week. In addition, the
vaccination rate only accounted for those ages 65 and older and those with underlying
health conditions; the vaccine efficacy for only one dose was found to be below 90% for all
three types of vaccines [17] [20]. With a chosen efficacy rate of only 89% and a small
portion of the susceptible population taking the vaccine, vaccine control measures had little
effect on the number of deaths and infections in only one week. This is observed in Figures
8, 9, and 11, which forecasted as many deaths as the CDC data revealed.
Meanwhile, the model for the fully vaccinated individuals observed a different effect in
Figures 15 to 21. By March 6, 2021, about 8% of the susceptible population in Mississippi
was fully vaccinated. Figure 20 shows that the system did not model vaccine administration
accurately after the ninth day; there were fewer vaccines administered than the system
predicted. Similarly, Figure 21 predicted far fewer deaths than the CDC data revealed.
Other figures during this time period also showed unrealistic infection and recovery
populations. On March 16, all ages 16 and above became eligible for the vaccine; however,
it takes more time for these additional people to be vaccinated if they so choose. Unlike
mask mandates and the Executive Stay At Home Order, this vaccine administration only
resulted in gradual changes to the spread of COVID-19 in Mississippi. In addition, a
hesitancy to receive the vaccine emerged in Mississippi as social and political factors
influenced the public perspective on vaccine safety. This combination of hesitancy and
vaccine administration processes was a likely cause of the low total fully vaccinated
population and slow vaccination rate, as well as the distance between the simulation and the
CDC vaccine data. A few days before the observed time period, the mask mandates for all
counties were lifted on March 2, 2021; masks were then only required in schools and when
social distancing was not possible [22]. Observing Figure 16, this policy change could be
the likely cause of the increase in asymptomatic individuals since those without symptoms
are less likely to wear a mask in public. If the symptomatic individual population was on a
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decline before this observed time period, the decreasing number of infected individuals may
have spurned the lifted mask mandate.
The time periods observed for this study collectively demonstrated the importance of
following recommended health guidelines and efficient vaccine administration. Only a
limited number of people could be vaccinated at a time due to the hindrance of lines, wait
times, and the number of available vaccines at a given location. More time was needed to
administer vaccines to the entire susceptible population than each individual taking direct
and immediate action themselves to slow the spread of COVID-19 in Mississippi. As a
short-term solution, social distancing and staying at home were immediate actions that each
susceptible individual could take at any given moment, restricting the spread more
efficiently than the initial vaccine administration. In addition, when the vaccine had yet to
be developed, these individual actions slowed the spread of the disease compared to what
the system predicted. Only when more vaccines were made available for a larger part of the
susceptible population did the vaccine administration prevent the spread of COVID-19 more
effectively than the preventions observed during the first week. Once a larger percentage of
the population has been vaccinated, we hope to observe a more controlled pandemic in
Mississippi.
Throughout our research, several new insights into the COVID-19 disease changed the
way we understand its infectiousness and spread across Mississippi. In addition, we learned
about the unfortunate hospitalizations and deaths of those who received their full dose of a
vaccine. These were caused by the more infectious variants that mutated from the original
virus. The Delta variant in the summer of 2021 and the Omicron variant in the winter of
2021 both contributed greatly to rising cases and deaths. These developments compelled us
to consider future improvement and research for our system of ordinary differential
equations.

Future Research
With the difficulties in developing an accurate model for the time period with vaccines,
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several key improvements can be attained in the model. First, the model should use the
initial number of infected people from an estimation by the number of confirmed cases.
This would ensure some better, if not realistic, results for the fourth experiment tested by
the ASIRD −V model. Limited time prevented this improvement in the model and the
requisite code from being developed. The unrealistic values in the fourth experiment were
used as an opportunity to learn where some faults in the model occurred. With more time
and research, we could make significant improvements to the ASIRD −V model.
Additional research would include modifying the model for longer time periods, which
may include developing a continuous function by which the parameters can account for
changes in policy and vaccination administrations. Such a function was seen in [23] and
could help expand the time period by which the model could reliably simulate. In addition,
if looking to expand the time for which the model can simulate, then the model could be
modified to include those individuals who become reinfected after recovery.
With these modifications, the model could be used to observe the effects of the control
measures, such as health policies and vaccinations, for other variants of COVID-19 that
have spread in Mississippi. Many variants of COVID-19 have shown to decrease the
efficacy of the vaccines [4]. Beginning with the Delta variant, the model could compare the
reproduction number of the spread of the Delta variant to the original variant and even the
Omicron variant. New research has shown that those with the vaccine, either one dose or
fully vaccinated, have a possibility of having severe symptoms, including death. Data has
recently been gathered for those with and without the vaccine becoming hospitalized. With
this new information, the ASIRD −V model could include a new compartment for those
vaccinated and hospitalized with COVID-19, as well as new parameters to measure the rate
of hospitalization and death for those vaccinated and infected with severe symptoms
compared to those asymptomatic and vaccinated individuals.
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APPENDIX A: CODE

1
2
3

4
5
6
7

function [w,resnorm] = ASIRDVModel
format long
p=[.05,0.001,0.05,0.05,0.05,0,0.05,0];% %initial guess for ...
optimization
lb=[0 0 0 0 0 0 0 0 ]; %lower bound;
ub=[50 5 5 5 5 5 5 5 ]; %upper bound;
options.StepTolerance = 1e-10;
options.FunctionTolerance=1e-10;

8
9
10
11

%from minimized cost function for t=20
[w,resnorm]= lsqnonlin(@myfun1,p,lb,ub,options)
MS=MSData; %MS death data and vaccine data

12
13
14
15
16
17
18
19
20
21
22
23

%parameters:alphaI-rate of I infection, alphaA-rate
%of asymptomatic (Au and Av) infection,
%xi-probability of becoming I, rhoS-recovery rate of I,
%rhoAu-recovery rate of Au
%rhoAv-recovery rate of Av, mu-death rate,
%nu-vaccination rate,
%tau-vacc. effectiveness
p= w;
alphaI=p(1);alphaA=p(2); xi=p(3);rhoS=p(4);
rhoAu=p(5); rhoAv=p(6); mu=p(7); nu=p(8); tau=0;
p=[ alphaI,alphaA, xi,rhoS,rhoAu, rhoAv, mu, nu, tau];

24
25
26
27
28
29
30
31
32
33
34

%initial conditions unified as proportion of total pop. of MS N=1
%(2,961,279) in 2020 0.19199e-3
I0=1.35e-6; Au0=1.24e-6;Av0=0; Ru0=0; Rv0=0; D0=0; V0=0;
S0=1-(I0+Au0+Av0+Ru0+Rv0+D0+V0);
options = odeset('RelTol',1e-4,'AbsTol',[1e-10 1e-10 1e-10
1e-10 1e-10 1e-10 1e-10 1e-10]);
%time interval from data [3/4/20-3/24/20: first 20 days in data]
T0=MS(1:29,1);
Y0=[S0,I0,Au0,Av0,Ru0,Rv0,D0,V0]; %,initial value
[T,Y]= ode45(@(t,y)ASIRDV(t,y,p),T0,Y0,options);

35
36
37
38

%reproduction number
r0=(((1-xi)*S0*alphaA)/(rhoAu))+
(((1-tau)*V0*alphaA)/(rhoAv))+((xi*S0*alphaI)/(rhoS+mu))

39
40
41
42
43
44
45
46
47
48

%plot against death data
figure(3) %plots solution of D(t)
hold on %holds previous plots; doesnt replace previous graphs
plot(T,Y(:,7),'c-') %plots solution curve red dots
DD=MSData; %edit for death data
plot(DD(1:29,1),DD(1:29,2)/(2.96*10^6),'k*')
ylabel('Death')
xlabel('Time (days)3/25-4/16')
legend('D', 'MS deaths data','Location','NorthEastOutside')
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49
50
51
52
53
54
55
56
57
58

%plot against vaccine data
figure(4)
hold on
plot(T,Y(:,8),'y-')
VV=MSData;
plot(VV(1:29,1),VV(1:29,8)/(2.96*10^6),'k*')
ylabel('Vaccinated')
xlabel('Time (days)3/25-4/16')
legend('V','MS Fully Vaccinated data', 'Location','NorthEastOutside')

59
60
61
62
63
64
65
66
67
68

%plots solution of I,Au,Av,Ru,Rv,D,V
figure(1)
hold on
%plots solution curve
plot(T,Y(:,2),'g-',T,Y(:,3),'r-',T,Y(:,4),'k-',...
T,Y(:,5),'b-',T,Y(:,6),'m-',T,Y(:,7),'c-')
ylabel('I-A_u-A_v-R_u-R_v-D-V')
xlabel('Time 3/4/2020-4/1/2020')
legend('I','A_u','A_v','R_u','R_v','D','Location', ...
'NorthEastOutside')

69
70
71
72
73
74
75
76

%plot solution of Ru
%figure(5)
%hold on
%plot(T,Y(:,5),'b-')
%ylabel('Ru')
%xlabel('Time 3/4/2020-4/1/2020')
%legend('Ru','Location','NorthEastOutside')

77
78
79
80
81
82
83

%plots solution of S
figure(2)
hold on
plot(T,Y(:,1),'r-')
ylabel('Susceptible')
xlabel('Time 3/4/2020-4/1/2020')

84
85
86
87
88
89

%optimize parameters
function [F]= myfun1(p) %uncontrolled epidemic phase (up to t=20)
format long
MS=MSData; %MS data
q=[p,0];

90
91
92
93

94
95

I0=1.35e-6; Au0=1.24e-6;Av0=0; Ru0=0;
Rv0=0; D0=0; V0=0; S0=1-(I0+Au0+Av0+Ru0+Rv0+D0+V0);
options = odeset('RelTol',1e-4,'AbsTol',[1e-10 1e-10 1e-10 1e-10 ...
1e-10 1e-10 1e-10 1e-10]);
T0=MS(1:20,1); %time interval from data
Y0=[S0,I0,Au0,Av0,Ru0,Rv0,D0,V0]; %,initial value

96
97

[T,Y]= ode45(@(t,y)ASIRDV(t,y,q),T0,Y0,options);

98
99
100

F= ((MS(1:20,2)/(2.96*10^6)-Y(T0,7))*(2.96*10^6))...
+((MS(1:20,8)/(2.96*10^6)-Y(T0,8))*(2.96*10^6));
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101
102
103
104
105
106
107
108
109

110
111
112
113
114
115
116
117
118

%solve system
function dy=ASIRDV(t,y,p) %nonlin ODE system function
format long
dy= zeros(8,1); %vector of 0
alphaI=p(1); alphaA=p(2); xi=p(3); rhoS=p(4); rhoAu=p(5);
rhoAv=0;mu=p(7); nu=0; tau=0;%parameter list
dy(1)=-y(1)*(alphaI*y(2)+alphaA*y(3)+alphaA*y(4))-nu*y(1);
dy(2)=xi*y(1)*(alphaI*y(2)+alphaA*y(3)+alphaA*y(4))-(rhoS ...
+mu)*y(2);
dy(3)=(1-xi)*y(1)*(alphaI*y(2)+alphaA*y(3)+alphaA*y(4))...
-rhoAu*y(3);
dy(4)=(1-tau)*y(8)*(alphaI*y(2)+alphaA*y(3)+alphaA*y(4))...
-rhoAv*y(4);
dy(5)=rhoS*y(2)+rhoAu*y(3);
dy(6)=rhoAv*y(4);
dy(7)=mu*y(2);
dy(8)=nu*y(1)-(1-tau)*y(8)*(alphaI*y(2)+alphaA*y(3)...
+alphaA*y(4));
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APPENDIX B: DATA
All data is downloaded from the CDC website [12][13].

Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Table B.1: March 4 to March 23, 2020
*Total doses for Janssen, Moderna and Pfizer vaccines
Total AdConfirmed
New
Fully Vacci- Confirmed
ministered J* M* P*
Deaths
Cases nated
Cases
Vaccines
0
0
0 0 0 6
0
4
1
0
0 0 0 2
0
5
2
0
0 0 0 12
0
16
2
0
0 0 0 8
0
24
4
0
0 0 0 11
0
35
5
0
0 0 0 35
0
70
6
0
0 0 0 25
0
94
11
0
0 0 0 23
0
117
13
0
0 0 0 35
0
153
15
0
0 0 0 37
0
189
23
0
0 0 0 41
0
230
28
0
0 0 0 71
0
300
37
0
0 0 0 96
0
391
43
0
0 0 0 80
0
469
53
0
0 0 0 112
0
580
59
0
0 0 0 95
0
674
70
0
0 0 0 125
0
797
78
0
0 0 0 98
0
894
83
0
0 0 0 92
0
986
86
0
0 0 0 165
0
1151
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Day
20
21
22
23
24
25
26
27
28
29

Table B.2: March 23 to April 1, 2020
*Total doses for Janssen, Moderna, and Pfizer vaccines
Total AdConfirmed
New
Fully Vacci- Confirmed
ministered J* M* P*
Deaths
Cases nated
Cases
Vaccines
86
0
0 0 0 165
0
1151
93
0
0 0 0 138
0
1288
102
0
0 0 0 132
0
1420
109
0
0 0 0 120
0
1540
117
0
0 0 0 165
0
1705
121
0
0 0 0 102
0
1807
128
0
0 0 0 102
0
1909
139
0
0 0 0 163
0
2071
153
0
0 0 0 151
0
2222
164
0
0 0 0 154
0
2374

Table B.3: December 16 to December 22, 2020
Total
Confirmed
Day
Administered Janssen Moderna
Deaths
Vaccines
288 5013
5
0
0
289 5049
74
0
1
290 5084
511
0
1
291 5116
1497
0
2
292 5141
2697
0
2
293 5193
2975
0
2
294 5230
3094
0
2
New
Fully
Confirmed
Day Pfizer
Cases Vaccinated Cases
288 5
2156 0
191002
289 73
2083 0
193085
290 509
2154 0
195239
291 1494 1972 0
197211
292 2663 1099 0
198310
293 2941 2160 0
200470
294 3060 2223 0
202693
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Day
368
369
370
371
372
373
374
375
376
377
378
Day
368
369
370
371
372
373
374
375
376
377
378

Table B.4: March 6 to March 16, 2021
Total
Confirmed
Administered Janssen
Moderna
Deaths
Vaccines
7074
736826
2099
401465
7074
764699
4728
415493
7083
776272
5325
417809
7091
780649
5473
418511
7096
801306
8485
428259
7110
823604
10876
439637
7117
824528
10877
440406
7119
896984
16911
477742
7120
896984
16911
477742
7129
904066
17446
480404
7131
906140
17525
481112
New
Fully
Confirmed
Pfizer
Cases Vaccinated Cases
332965
201
262010
298946
344100
156
273824
299102
352744
433
278797
299535
356271
457
280373
299992
364099
511
289830
300503
372596
656
298373
301159
372750
395
298916
301554
401756
201
326150
301755
401756
156
326212
301911
405641
418
329254
302329
406928
283
329647
302612
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